What is the typical length of Cas9 mRNA?

The SpCas9 coding sequence is approximately 4.2 kb. Including 5′ and 3′ UTRs and a poly(A) tail of 120–150 nucleotides, the complete transcript is typically 4.5–4.7 kb.

What dsRNA level is acceptable for Cas9 mRNA?

High-purity specifications target dsRNA below 0.1% of total RNA mass, measured by ELISA with anti-dsRNA antibody (clone J2). In sensitive primary cells such as T cells and HSPCs, even levels between 0.1% and 0.5% may cause measurable interferon activation.

Why is m1Ψ used in Cas9 mRNA instead of standard uridine?

N(1)-methyl-pseudouridine reduces recognition by pattern recognition receptors including TLR7, TLR8, and RIG-I, decreasing innate immune activation and enhancing translation efficiency, resulting in higher functional nuclease yield per microgram of delivered RNA.

Does higher capping efficiency always improve editing outcomes?

High capping efficiency (>95%) generally supports stronger and more consistent Cas9 protein translation, but excessive expression in active cell lines may trigger DNA damage responses. High capping efficiency ensures the specified dose reaches ribosomes; it does not eliminate the need for dose optimization.

Is Cas9 mRNA suitable for in vivo delivery?

Yes. Cas9 mRNA is compatible with LNP delivery systems and has been used in preclinical in vivo models targeting the liver, lung, and other tissues. Co-formulation of Cas9 mRNA with gRNA in a single LNP is the standard approach.

Our Blog

How to Choose the Best Cas9 mRNA for Gene Editing

The best Cas9 mRNA for gene editing is defined by transcript integrity, dsRNA content, capping efficiency, nucleotide modification strategy, and functional validation in a cell-based potency assay. This guide explains what how to evaluate batch data, for researchers working proof of concept to early IND-enabling studies.

``` --- ### Meta Excerpt ``` The best Cas9 mRNA for gene editing is defined by five measurable quality attributes: transcript integrity, dsRNA content, capping efficiency, nucleotide modification strategy, and functional validation in a cell-based potency assay. This guide explains what makes Cas9 mRNA technically demanding to manufacture, which quality thresholds to require from a supplier, and how to evaluate batch data — for researchers working from guide optimization through early IND-enabling studies.;